Back
Adaptive Biotechnologies Quote, Financials, Valuation and Earnings
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
34
ADPT
Adaptive Biotechnologies
Last Price:
2.75
Seasonality Move:
1.15%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!Adaptive Biotechnologies Price Quote
$2.75
+0.15 (+5.77%)
(Updated: April 29, 2024 at 6:55 PM ET)
Adaptive Biotechnologies Key Stats
Sell
34
Adaptive Biotechnologies (ADPT)
is a Sell
Day range:
$2.56 - $2.73
52-week range:
$2.28 - $9.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.20
P/B ratio:
1.22%
Volume:
1.1M
Avg. volume:
1.9M
1-year change:
-64.51%
Market cap:
$377.2M
Revenue:
$170.3M
EPS:
$-1.56
How Much Does Adaptive Biotechnologies Make?
-
How Much Are Adaptive Biotechnologies's Sales Annually?
ADPT Revenues are $170.3M -
How Much Profit Does Adaptive Biotechnologies's Make A Year?
ADPT net income is -$225.3M
Is Adaptive Biotechnologies Growing As A Company?
-
What Is Adaptive Biotechnologies's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.17% -
What Is Adaptive Biotechnologies's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Adaptive Biotechnologies Stock Price Performance
-
Did Adaptive Biotechnologies Stock Go Up Last Month?
Adaptive Biotechnologies share price went down by -9.72% last month -
Did ADPT's Share Price Rise Over The Last Year?
ADPT share price fell by -64.51% over the past 1 year
What Is Adaptive Biotechnologies 52-Week High & Low?
-
What Is Adaptive Biotechnologies’s 52-Week High Share Price?
Adaptive Biotechnologies has traded as high as $9.08 over the past 52 weeks -
What Is Adaptive Biotechnologies’s 52-Week Low Share Price?
Adaptive Biotechnologies has traded as low as $2.28 over the past 52 weeks
Adaptive Biotechnologies Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Adaptive Biotechnologies?
-
How Much Debt Does Adaptive Biotechnologies Have?
Total long term debt quarterly is $0 -
How Much Cash Does Adaptive Biotechnologies Have?
Cash and short term investments quarterly total is $346.4M -
What Is Adaptive Biotechnologies’s Book Value Per Share?
Book value per share is 2.13
Is Adaptive Biotechnologies Cash Flow Positive?
-
What Is ADPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$156.3M -
What Is Adaptive Biotechnologies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $2.2M -
What Is Adaptive Biotechnologies’s Cash Flow From Investing?
Cash flow from investing (TTM) is $129.6M
Adaptive Biotechnologies Return On Invested Capital
-
Is Management Doing A Good Job?
ADPT return on invested capital is -57.64% -
What Is Adaptive Biotechnologies Return On Assets?
ROA measures how assets are converting to revenues and is -29.71% -
What Is ADPT Return On Equity?
ROE is a measure of profitability and is -57.64%
Adaptive Biotechnologies Earnings Date & Stock Price
-
What Is Adaptive Biotechnologies's Stock Price Today?
A single share of ADPT can be purchased today for 2.60 -
What Is Adaptive Biotechnologies’s Stock Symbol?
Adaptive Biotechnologies trades on the nasdaq under the ticker symbol: ADPT -
When Is Adaptive Biotechnologies’s Next Earnings Date?
The next quarterly earnings date for Adaptive Biotechnologies is scheduled on May 7, 2024 -
When Is ADPT's next ex-dividend date?
Adaptive Biotechnologies's next ex-dividend date is June 4, 2020 -
How To Buy Adaptive Biotechnologies Stock?
You can buy Adaptive Biotechnologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Adaptive Biotechnologies Competitors
-
Who Are Adaptive Biotechnologies's Competitors?
Below is a list of companies who compete with Adaptive Biotechnologies or are related in some way:
Adaptive Biotechnologies Dividend Yield
Data Unavailable
Adaptive Biotechnologies Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 6.99% |
| Revenue: | -17.06% | -5.53% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 6.67 |
| Upside from Last Price: | 156.41% |